Risk factors associated with acute hip prosthetic joint infections and outcome of treatment with a rifampinbased regimen

Acta Orthop. 2007 Dec;78(6):755-65. doi: 10.1080/17453670710014527.

Abstract

Background and purpose: Acute prosthetic infection is a serious problem. We report factors related to the incidence of acute infection and results of combined joint debridement and prolonged rifampicin-based antibiotic therapy.

Patients and methods: Between 1998 and 2004, 14 acute infections occurred after 819 primary hip arthroplasties. The association between patient-related and surgical factors and the risk of infection were analyzed. Infections were treated with multiple joint lavage, debridement, 2 weeks of antibiotic therapy, and then oral antibiotics for a minimum of 6 months.

Results: There was a correlation between having a body mass index (BMI) of >or=30, and also more than 2 co-morbidities, and an increased risk of infection. Diabetes was a potential risk factor. Following our regime of treatment, 11 of 14 patients retained their prosthesis. 2 of 3 who required resection arthroplasty underwent successful staged revision, while the third patient had no further surgery because of being deemed unfit.

Interpretation: Primary joint replacement was salvaged in 11 of 14 patients. When successful re-implantation was included, 13 of 14 patients had a mobile prosthetic joint without further infection.

MeSH terms

  • Acute Disease
  • Aged
  • Anti-Bacterial Agents / therapeutic use*
  • Arthroplasty, Replacement, Hip / adverse effects*
  • Female
  • Follow-Up Studies
  • Hip Prosthesis / adverse effects
  • Humans
  • Male
  • Middle Aged
  • Prosthesis Design
  • Prosthesis Failure
  • Prosthesis-Related Infections / drug therapy*
  • Prosthesis-Related Infections / microbiology
  • Reoperation
  • Rifampin / therapeutic use*
  • Risk Factors
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Rifampin